Want to join the conversation?
$PFE 2Q15 PR: In vaccines, the company recently started a Phase 2b study for Staph aureus vaccine and depending upon the results this could serve as a registrational study. On July, Pfizer initiated a Phase 2 study to evaluate the safety, tolerability and immunogenicity of investigational C. difficile vaccine.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!